Regeneron, Sanofi tease potential expanded collaboration for Dupixent follow-ons
Regeneron and Sanofi said they are in the early stages of discussing areas for further collaboration, building on one of the most fruitful pharmaceutical company partnerships in recent history. An expanded deal could include follow-on ...
Regeneron and Sanofi said they are in the early stages of discussing areas for further collaboration, building on one of the most fruitful pharmaceutical company partnerships in recent history.
An expanded deal could include follow-on ...
Source: Endpoints News